139 related articles for article (PubMed ID: 34601984)
21. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
Xu W; Fu J; Wu H; Sun W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
[TBL] [Abstract][Full Text] [Related]
22. 17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.
Wang Y; Ma X; Yan S; Shen S; Zhu H; Gu Y; Wang H; Qin G; Yu Q
Cancer Res; 2009 Sep; 69(18):7302-10. PubMed ID: 19706767
[TBL] [Abstract][Full Text] [Related]
23. Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases.
Liu M; Xiao C; Sun M; Tan M; Hu L; Yu Q
Molecules; 2018 Jun; 23(6):. PubMed ID: 29921758
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas.
Osuka K; Watanabe Y; Usuda N; Aoyama M; Iwami K; Takeuchi M; Watabe T; Takayasu M
J Neurotrauma; 2017 Jun; 34(11):1996-2000. PubMed ID: 28027695
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.
Judd LM; Menheniott TR; Ling H; Jackson CB; Howlett M; Kalantzis A; Priebe W; Giraud AS
PLoS One; 2014; 9(5):e95993. PubMed ID: 24804649
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
27. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
[TBL] [Abstract][Full Text] [Related]
28. NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway.
Wang H; Fu Y
BMC Cancer; 2021 Jul; 21(1):871. PubMed ID: 34330232
[TBL] [Abstract][Full Text] [Related]
29. Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer.
Wu CS; Wei KL; Chou JL; Lu CK; Hsieh CC; Lin JM; Deng YF; Hsu WT; Wang HM; Leung CH; Ma DL; Li C; Chan MW
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598141
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
31. Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK/STAT3 signaling pathway.
Du L; Chang H; Xu W; Wei Y; Wang Y; Yin L; Zhang X
Life Sci; 2020 Oct; 258():118217. PubMed ID: 32768575
[TBL] [Abstract][Full Text] [Related]
32. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone inhibits the JAK/STAT3 pathway by regulating SOCS1 in endometrial cells
Li H; Sun N; Zhu Y; Wang W; Cai M; Luo X; Xia W; Quan S
Eur J Histochem; 2023 Jan; 67(1):. PubMed ID: 36546418
[TBL] [Abstract][Full Text] [Related]
34. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.
Fiebelkow J; Guendel A; Guendel B; Mehwald N; Jetka T; Komorowski M; Waldherr S; Schaper F; Dittrich A
Cell Commun Signal; 2021 Sep; 19(1):94. PubMed ID: 34530865
[TBL] [Abstract][Full Text] [Related]
35. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
[TBL] [Abstract][Full Text] [Related]
36. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
[TBL] [Abstract][Full Text] [Related]
37. Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway.
Ham IH; Wang L; Lee D; Woo J; Kim TH; Jeong HY; Oh HJ; Choi KS; Kim TM; Hur H
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35621145
[TBL] [Abstract][Full Text] [Related]
38. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC.
Wang S; Zhang W
Tumour Biol; 2016 May; 37(5):6561-9. PubMed ID: 26638167
[TBL] [Abstract][Full Text] [Related]
40. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]